News

In this Financial Times piece our CEO is reflecting on raising concerns about the lab spaces for rent within science clusters. 

This piece covers how bit.bio's technology is also used by Meatable for their cultured meat products.

Dr Farah Patell-Socha and Furqan Iqbal interviewed in the latest issue of Technology Networks.

VP of Research Products Dr Farah Patell-Socha discusses more accurate cell models in neurodegeneration.

bit.bio expands senior team with four female hires in further preparation for cell therapies.

bit.bio and Charles River Laboratories discuss the potential of precision reprogrammed human cells.

The piece talks about how bit.bio has "cracked the code" to grow human cells for a new era of regenerative medicine. 

Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.